{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:43:24Z","timestamp":1697442204736},"reference-count":12,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1395,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1998,3]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Agranulocytosis is a serious side effect of anti\u2010thyroid drugs (ATD). Granulocyte colony\u2010stimulating factor (G\u2010CSF) is one of the cytokines that increase granulocyte number. The aim of this study was to examine the sequential variation of serum G\u2010CSF levels in patients with Graves' disease before and after ATD therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS<\/jats:title><jats:p>Sixty\u2010three patients with Graves' disease were studied before, during and after treatment with methimazole (MMI). Serum samples from 71 healthy subjects were used as controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN AND MEASUREMENTS<\/jats:title><jats:p>Serum levels of G\u2010CSF were measured by a novel chemiluminescent enzyme immunoassay, which was sensitive enough to determine G\u2010CSF levels in healthy subjects. Blood granulocyte counts, serum, thyroid hormone and TSH levels, and titres of thyroid autoantibodies were also measured.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Serum G\u2010CSF levels in Graves' patients before and 2 weeks after MMI were significantly higher than in healthy subjects. There was a significant correlation between serum G\u2010CSF levels and granulocyte counts in untreated patients with Graves' disease. Untreated patients with granulocyte counts less than 2\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l had significantly lower serum G\u2010CSF levels as compared with other untreated patients. Serum G\u2010CSF levels gradually decreased thereafter. No correlation was observed between serum G\u2010CSF levels and serum thyroid hormone levels or titres of thyroid autoantibodies. After ATD treatment, no correlation was found between serum G\u2010CSF levels and granulocytes counts. There was no significant correlation between the change of serum G\u2010CSF levels and that of granulocyte counts before and after MMI treatment. Graves' patients with mild agranulocytosis had normal or elevated serum G\u2010CSF levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Significantly elevated serum G\u2010CSF levels were observed in patients with Graves' hyperthyroidism. During ATD therapy, deficiency of G\u2010CSF was not identified as a cause of agranulocytosis in this study.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1998.00422.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:35:54Z","timestamp":1047378954000},"page":"275-280","source":"Crossref","is-referenced-by-count":6,"title":["Elevated serum granulocyte colony\u2010stimulating factor levels in patients with Graves' disease"],"prefix":"10.1111","volume":"48","author":[{"given":"Makoto","family":"Iitaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeduk Yoshimura","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kitahama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehiro","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-1-26"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198411223112106"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92980-8"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrine1927.68.10_1121"},{"key":"e_1_2_6_6_2","first-page":"216","article-title":"Peripheral blood leucocytes in thyrotoxicosis (Graves' disease) as studied by conventional light microscopy","volume":"27","author":"Irvine W.J.","year":"1977","journal-title":"Clinical and Experimental Immunology"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(93)90048-9"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01852164"},{"key":"e_1_2_6_9_2","first-page":"339","article-title":"Agranulocytosis and antithyroid drugs","volume":"126","author":"Rosove M.H.","year":"1977","journal-title":"Western Journal of Medicine"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"antithyroid drugs\u2010induced agranulocytosis: the usefulness of routine white blood cell count monitoring","volume":"150","author":"Tajiri J.","year":"1990","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.153.4.509"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/009127006200200603"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-5-868"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00422.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00422.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.00422.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:09:37Z","timestamp":1697440177000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1998.00422.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["10.1046\/j.1365-2265.1998.00422.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00422.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}